Skandinaviska Enskilda Banken (SEB)
IMGN

Skandinaviska Enskilda Banken (SEB)’s Immunogen Inc IMGN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-98,515
Closed -$2.92M – 980
2023
Q4 		$2.92M Buy
98,515
+50,000
+103% +$996K 0.02% 496
2023
Q3 		$769K Buy
+48,515
New +$807K 0.01% 717
2020
Q3 		– Sell
-142,200
Closed -$653K – 1130
2020
Q2 		$653K Buy
+142,200
New +$605K 0.01% 780

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IMGN Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 98,515 shares — an estimated $2.92M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IMGN in Q2 2020 and held it in 3 quarters. The position peaked at $2.92M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 98,515 Immunogen Inc shares in Q1 2024, an estimated $2.92M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Immunogen Inc in Q2 2020 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Immunogen Inc position peaked at $2.92M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.